NSE · ASTRAZEN
AstraZeneca Pharma India Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#425
of 5,072 stocks
▼ 111W
Peak #414 · 21 Sep 2026
Operating in Healthcare, AstraZeneca Pharma India Limited carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and generates a high return on equity.
Market Cap
16,262.50 Cr
P/E Ratio
86.72
P/B Ratio
18.63
ROE
21.49%
ROCE
26.00%
Dividend Yield
0.55%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 682.79 Cr | 578.61 Cr | 611.57 Cr | 559.09 Cr |
| Net Profit | 37.93 Cr | 44.88 Cr | 32.59 Cr | 54.22 Cr |
| EPS | 15.17 | 17.95 | 13.04 | 21.69 |
| Operating Profit | 52.94 Cr | 61.26 Cr | 46.12 Cr | 78.78 Cr |
Shareholding pattern
Promoter
75.00%
Public
25.00%
PUBLIC BREAKDOWN
FII
2.68%
DII
6.08%
MF (within DII)
6.01%
Individuals
14.12%
Mutual fund holdings
₹1,046.89
Cr total
20
Schemes
6
Fund Houses
₹1,046.89 Cr
Total Exposure
Nippon India Mutual Fund₹503.60 Cr (48.1%)
ICICI Prudential Mutual Fund₹377.78 Cr (36.1%)
Bandhan Mutual Fund₹110.20 Cr (10.5%)
Baroda BNP Paribas Mutual Fund₹40.46 Cr (3.9%)
UTI Mutual Fund₹14.72 Cr (1.4%)
Others₹0.13 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 31 Jul 2026 | Dividend | Dividend - Rs 36 Per Share |
| 18 Jul 2025 | Dividend | Dividend - Rs 32 Per Share |
| 05 Jul 2024 | Dividend | Dividend - Rs 24 Per Share |
| 14 Jul 2023 | Dividend | Dividend - Rs 16 Per Share |
| 07 Jul 2022 | Dividend | Dividend - Rs 8 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.